Simon Tate - 18 May 2023 Form 4 Insider Report for Eliem Therapeutics, Inc. (CLYM)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELYM	Stock Option (Right To Buy)	Award	$0	+10,000		$0.000000	10,000	18 May 2023	Common Stock	10,000	$3.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares subject to the option will vest on the earlier of May 18, 2024 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.